The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article that was recently published in the New England Journal of Medicine.
FDA receives more reports of deaths linked to Philips’ recalled respiratory devices
Dive Brief: The Food and Drug Administration has received more medical device reports (MDRs) linked to Philips’ respiratory products that include reports of death, according to